In another development on the same day, Molecular Templates received a written notice from Nasdaq, stating that the bid price of the company’s common stock had closed below the minimum $1.00 per ...
Molecular Templates, Inc. (NASDAQ:MTEM), a pharmaceutical company with a market capitalization of just $2.34 million, has been notified of its pending delisting from the Nasdaq Stock Market. The ...
Molecular Templates, Inc. (NASDAQ:MTEM), a pharmaceutical company with a market capitalization of just $2.34 million, has been notified of its pending delisting from the Nasdaq Stock Market. The ...
Molecular Templates, Inc. (NASDAQ:MTEM), a pharmaceutical company with a market capitalization of just $2.34 million, has been notified of its pending delisting from the Nasdaq Stock Market.
Molecular Templates, Inc., a clinical-stage biopharmaceutical company focused on developing cancer therapies, has been informed by Nasdaq that it is deemed a "public shell" and its continuation on ...